Business Description
Founded in Shanghai in 2011, Hua Medicine is a Chinese pharmaceutical company focused on discovering and bringing to market new treatments for diabetes and related conditions. Its flagship product, Dorzagliatin, is an oral medication for Type 2 Diabetes that can be used alone or alongside several other established treatments. The company is also exploring broader applications of its core technology, including treatments for obesity, Parkinson's disease complications, drug addiction, and early-stage Alzheimer's disease.
